ダウンロード数: 551
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
34_1273.pdf | 292.45 kB | Adobe PDF | 見る/開く |
タイトル: | 尿路性器癌骨転移の骨性疼痛に対するエルシトニン(R)の検討 |
その他のタイトル: | Experience of Elcitonin treatment in metastatic bony pain of urological tumors |
著者: | 徳中, 荘平 藤井, 敬三 岡村, 廉晴 橋本, 博 藤沢, 真 宮田, 昌伸 有馬, 滋 八竹, 直 |
著者名の別形: | Tokunaka, Sohei Fujii, Hiromitsu Okamura, Kiyoharu Hashimoto, Hiroshi Fujisawa, Makoto Miyata, Masanobu Arima, Shigeru Yachiku, Sunao |
キーワード: | Aged Aged, 80 and over Bone Neoplasms/physiopathology/secondary Calcitonin/analogs & derivatives/therapeutic use Carcinoma, Renal Cell/pathology/physiopathology Humans Kidney Neoplasms/pathology/physiopathology Male Middle Aged Pain Measurement Pain, Intractable/drug therapy Prostatic Neoplasms/pathology/physiopathology |
発行日: | Jul-1988 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 34 |
号: | 7 |
開始ページ: | 1273 |
終了ページ: | 1277 |
抄録: | Fourteen cases of urogenital tumors (9 prostatic carcinomas, 4 renal cell carcinomas and 1 bladder carcinoma) which had bone metastases were treated with eel-calcitonin, Elcitonin injections for relief of bony pain. Forty mgs. of Elcitonin was injected intramuscularly, 2 to 3 times a week, to out-patients. Forty to 80 mgs. of Elcitonin was injected intramuscularly, daily to hospitalized patients. Relief of the pain was obtained in 71.4% of all patients (71.4% of out-patients and 71.4% of hospitalized patients) and especially in 88.9% of prostatic carcinoma patients. Hypercalcemia was seen in only one patient of renal cell carcinoma. It is considered that Elcitonin treatment is useful for relief of bony pain in the patients with bone metastases, with or without hypercalcemia. |
URI: | http://hdl.handle.net/2433/119626 |
PubMed ID: | 3177147 |
出現コレクション: | Vol.34 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。